Tuning Adipocyte Size and Obesity through SWELL1
通过 SWELL1 调节脂肪细胞大小和肥胖
基本信息
- 批准号:10649660
- 负责人:
- 金额:$ 41.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-05-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AdipocytesAdipose tissueAnionsBiochemicalCRISPR screenCRISPR/Cas technologyCell membraneComplexDiabetes MellitusDietDiseaseE proteinEndotheliumFRAP1 geneFundingGLUT 4 proteinGenesGlucose IntoleranceGrowthHealthHigh Fat DietHumanImageIn VitroIncidenceInsulinInsulin ResistanceIon ChannelKnock-in MouseKnock-outKnowledgeLabelLaboratoriesLeucineLeucine-Rich RepeatLysosomesMass Spectrum AnalysisMeasuresMediatingMetabolicMetabolic syndromeMethodsMissionModelingMolecularMusNational Institute of Diabetes and Digestive and Kidney DiseasesNon-Insulin-Dependent Diabetes MellitusNutrientObese MiceObesityOrganOvernutritionPIK3CG genePathway interactionsPatientsPopulationPrediabetes syndromeProto-Oncogene Proteins c-aktPublishingReagentResearchSignal PathwaySignal TransductionSkeletal MuscleSocietiesSwellingTestingTherapeuticTissue ExpansionTissue SampleTissuesVisceraladipocyte biologyarmdefined contributiondetection of nutrientexperimental studyglucose uptakegrowth factor receptor-bound protein 2human tissuein vivoinflammatory markerinnovationinsulin secretioninsulin sensitivitymetabolic phenotypemutantnovelobesity preventionobesity treatmentoverexpressionpatch clampprotein expressionresponsesuperresolution microscopy
项目摘要
Project Summary
Healthy adipose tissue expansion is necessary for maintaining metabolic health in the setting of over-nutrition –
a situation that is increasingly relevant in the US, as the incidence of obesity is estimated at 33% of the US
population. Therefore, elucidating the fundamental nutrient sensing mechanisms that regulate adipocyte
expansion is critical for understanding, and ultimately treating, the negative metabolic consequences of obesity.
We previously identified Leucine Rich Repeat Containing 8A (LRRC8a or SWELL1), a newly discovered
essential component of the volume-regulated anion channel (VRAC), as a novel volume-sensing regulator of
both insulin sensitivity and insulin secretion. We and others find that SWELL1 activity and protein expression is
reduced in metabolically unhealthy obese mice and humans – suggesting that reduced multi-organ SWELL1
activity/expression contributes to obesity-induced metabolic syndrome. Our group has biochemical, patch-
clamp and imaging evidence that SWELL1 channel complexes are also expressed and functional in
lysosomes. Given that lysosomes are signaling hubs that integrate nutrient sensing and AKT-mTOR signaling,
we hypothesize that lysosomal SWELL1-LRRC8 channels participate in cellular nutrient sensing by
activating in response to increases in intraluminal lysosomal leucine, and that this signaling mechanism
is dysregulated in the setting of obesity-induced diabetes and insulin resistance. To test this hypothesis,
we combine unique reagents and innovative methods from the Diwan (lysosomal signaling), Xu (lysosomal
patch-clamp), and Held (mass spectrometry) laboratories, with our expertise in SWELL1 signaling, and access
to human adipose tissue samples from highly phenotyped metabolically healthy and unhealthy humans (Klein
laboratory). Our objective is to understand the mechanisms of plasma membrane and lysosomal SWELL1 (Lyso-
SWELL1) nutrient sensing and how it is dysregulated in disease states, including obesity-induced glucose
intolerance and insulin resistance. The rationale for these studies is that delineating the contribution of SWELL1
to lysosomal nutrient sensing and mTORC1 activation will advance our understanding of a fundamental cellular
signaling mechanism and guide innovative therapeutic approaches for patients with prediabetes and diabetes.
We propose the following AIMs:
· AIM#1: Delineate the mechanisms of plasma membrane versus lysosomal SWELL1 signaling to AKT-
AMPK-mTOR signaling in adipocytes
· AIM#2: Examine the contribution of SWELL1 signaling in vivo in the setting of obesity in mice and
humans
The knowledge gained from these studies will delineate a novel lysosomal ion channel signaling pathway that
regulates adipocyte growth and systemic dysglycemia in obesity, and inform therapeutic strategies currently
underway to modulate SWELL1 signaling for the treatment of obesity-induced metabolic syndrome.
项目摘要
健康的脂肪组织扩张对于在营养过剩的情况下维持代谢健康是必要的-
这种情况在美国越来越重要,因为肥胖的发病率估计为美国的33%,
人口因此,阐明调节脂肪细胞的基本营养感受机制,
扩张对于理解和最终治疗肥胖的负面代谢后果至关重要。
我们以前发现了富含亮氨酸重复序列的8A(LRRC 8a或SWELL 1),这是一种新发现的蛋白质。
体积调节阴离子通道(VRAC)的重要组成部分,作为一种新型的体积感应调节剂,
胰岛素敏感性和胰岛素分泌。我们和其他人发现,SWELL 1活性和蛋白质表达是
在代谢不健康的肥胖小鼠和人类中减少-这表明减少的多器官SWELL 1
活性/表达有助于肥胖诱导的代谢综合征。我们组有生化的,补丁-
钳和成像证据表明,SWELL 1通道复合物也表达和功能,
溶酶体考虑到溶酶体是整合营养感测和AKT-mTOR信号传导的信号中枢,
我们假设溶酶体SWELL 1-LRRC 8通道通过以下途径参与细胞营养感受:
激活响应于管腔内溶酶体亮氨酸的增加,并且这种信号传导机制
在肥胖引起的糖尿病和胰岛素抵抗的情况下是失调的。为了验证这个假设,
我们结合联合收割机独特的试剂和创新的方法,从Diwan(溶酶体信号),Xu(溶酶体
膜片钳)和Held(质谱)实验室,我们在SWELL 1信号传导方面的专业知识,
对来自高度表型化的代谢健康和不健康的人的人脂肪组织样品(Klein
实验室)。我们的目标是了解质膜和溶酶体SWELL 1(Lyso-1)的机制。
SWELL 1)营养感应及其在疾病状态下如何失调,包括肥胖诱导的葡萄糖
不耐受和胰岛素抵抗。这些研究的基本原理是描述SWELL 1的贡献
溶酶体营养传感和mTORC 1激活将促进我们对基本细胞的理解
信号传导机制,并指导糖尿病前期和糖尿病患者的创新治疗方法。
我们提出以下目标:
· AIM#1:描述质膜相对于溶酶体SWELL 1信号传导至AKT的机制。
脂肪细胞中的AMPK-mTOR信号传导
· AIM#2:检查SWELL 1信号传导在小鼠肥胖情况下的体内贡献,
人类
从这些研究中获得的知识将描绘一种新的溶酶体离子通道信号通路,
调节肥胖症中的脂肪细胞生长和全身性功能障碍,并为目前的治疗策略提供信息。
正在进行中,以调节SWELL 1信号传导,用于治疗肥胖诱导的代谢综合征。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Isolation and Patch-Clamp of Primary Adipocytes.
原代脂肪细胞的分离和膜片钳。
- DOI:10.1007/978-1-4939-6820-6_14
- 发表时间:2017
- 期刊:
- 影响因子:0
- 作者:Zhang,Yanhui;Tong,Dan;Mishra,Anil;Xie,Litao;Samuel,Isaac;Smith,JessicaK;Sah,Rajan
- 通讯作者:Sah,Rajan
The volume-regulated anion channel (LRRC8) in nodose neurons is sensitive to acidic pH.
- DOI:10.1172/jci.insight.90632
- 发表时间:2017-03
- 期刊:
- 影响因子:8
- 作者:Runping Wang;Yongjun Lu;Susheel K. Gunasekar;Yanhui Zhang;C. Benson;M. Chapleau;R. Sah;F. Abboud
- 通讯作者:Runping Wang;Yongjun Lu;Susheel K. Gunasekar;Yanhui Zhang;C. Benson;M. Chapleau;R. Sah;F. Abboud
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rajan Sah其他文献
Rajan Sah的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rajan Sah', 18)}}的其他基金
SWELL1-LRRC8 mediated regulation of skeletal muscle function and metabolism
SWELL1-LRRC8 介导的骨骼肌功能和代谢调节
- 批准号:
10618270 - 财政年份:2021
- 资助金额:
$ 41.26万 - 项目类别:
Optimizing small molecule SWELL1-LRRC8 modulators to treat Type 2 diabetes
优化小分子 SWELL1-LRRC8 调节剂治疗 2 型糖尿病
- 批准号:
10216501 - 财政年份:2021
- 资助金额:
$ 41.26万 - 项目类别:
Optimizing small molecule SWELL1-LRRC8 modulators to treat Type 2 diabetes
优化小分子 SWELL1-LRRC8 调节剂治疗 2 型糖尿病
- 批准号:
10430129 - 财政年份:2021
- 资助金额:
$ 41.26万 - 项目类别:
SWELL1-LRRC8 mediated regulation of skeletal muscle function and metabolism
SWELL1-LRRC8 介导的骨骼肌功能和代谢调节
- 批准号:
10454421 - 财政年份:2021
- 资助金额:
$ 41.26万 - 项目类别:
Optimizing small molecule SWELL1-LRRC8 modulators to treat Type 2 diabetes
优化小分子 SWELL1-LRRC8 调节剂治疗 2 型糖尿病
- 批准号:
10617838 - 财政年份:2021
- 资助金额:
$ 41.26万 - 项目类别:
SWELL1-LRRC8 mediated regulation of skeletal muscle function and metabolism
SWELL1-LRRC8 介导的骨骼肌功能和代谢调节
- 批准号:
10305237 - 财政年份:2021
- 资助金额:
$ 41.26万 - 项目类别:
Ion channel regulation of pancreatic islet cell function
离子通道对胰岛细胞功能的调节
- 批准号:
10249948 - 财政年份:2020
- 资助金额:
$ 41.26万 - 项目类别:
Ion channel regulation of pancreatic islet cell function
离子通道对胰岛细胞功能的调节
- 批准号:
10477248 - 财政年份:2020
- 资助金额:
$ 41.26万 - 项目类别:
Ion channel regulation of pancreatic islet cell function
离子通道对胰岛细胞功能的调节
- 批准号:
10664931 - 财政年份:2020
- 资助金额:
$ 41.26万 - 项目类别:
Tuning fat cell size and obesity through SWELL1
通过 SWELL1 调节脂肪细胞大小和肥胖
- 批准号:
9917773 - 财政年份:2018
- 资助金额:
$ 41.26万 - 项目类别:
相似海外基金
Deciphering the role of adipose tissue in common metabolic disease via adipose tissue proteomics
通过脂肪组织蛋白质组学解读脂肪组织在常见代谢疾病中的作用
- 批准号:
MR/Y013891/1 - 财政年份:2024
- 资助金额:
$ 41.26万 - 项目类别:
Research Grant
ESTABLISHING THE ROLE OF ADIPOSE TISSUE INFLAMMATION IN THE REGULATION OF MUSCLE MASS IN OLDER PEOPLE
确定脂肪组织炎症在老年人肌肉质量调节中的作用
- 批准号:
BB/Y006542/1 - 财政年份:2024
- 资助金额:
$ 41.26万 - 项目类别:
Research Grant
Activation of human brown adipose tissue using food ingredients that enhance the bioavailability of nitric oxide
使用增强一氧化氮生物利用度的食品成分激活人体棕色脂肪组织
- 批准号:
23H03323 - 财政年份:2023
- 资助金额:
$ 41.26万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of new lung regeneration therapies by elucidating the lung regeneration mechanism of adipose tissue-derived stem cells
通过阐明脂肪组织干细胞的肺再生机制开发新的肺再生疗法
- 批准号:
23K08293 - 财政年份:2023
- 资助金额:
$ 41.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Canadian Alliance of Healthy Hearts and Minds: Dissecting the Pathways Linking Ectopic Adipose Tissue to Cognitive Dysfunction
加拿大健康心灵联盟:剖析异位脂肪组织与认知功能障碍之间的联系途径
- 批准号:
479570 - 财政年份:2023
- 资助金额:
$ 41.26万 - 项目类别:
Operating Grants
Determinants of Longitudinal Progression of Adipose Tissue Inflammation in Individuals at High-Risk for Type 2 Diabetes: Novel Insights from Metabolomic Profiling
2 型糖尿病高危个体脂肪组织炎症纵向进展的决定因素:代谢组学分析的新见解
- 批准号:
488898 - 财政年份:2023
- 资助金额:
$ 41.26万 - 项目类别:
Operating Grants
A study on the role of brown adipose tissue in the development and maintenance of skeletal muscles
棕色脂肪组织在骨骼肌发育和维持中作用的研究
- 批准号:
23K19922 - 财政年份:2023
- 资助金额:
$ 41.26万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
A mechanism of lipid accumulation in brown adipose tissue
棕色脂肪组织中脂质积累的机制
- 批准号:
10605981 - 财政年份:2023
- 资助金额:
$ 41.26万 - 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
- 批准号:
10813753 - 财政年份:2023
- 资助金额:
$ 41.26万 - 项目类别:
Estrogen Signaling in the Ventromedial Hypothalamus Modulates Adipose Tissue Metabolic Adaptation
下丘脑腹内侧区的雌激素信号调节脂肪组织代谢适应
- 批准号:
10604611 - 财政年份:2023
- 资助金额:
$ 41.26万 - 项目类别: